Herpes Zoster pada Lansia Diabetes Melitus

Authors

  • Olivia Christy Kaihatu Puskesmas Perawatan Allang, Desa Allang, Kabupaten Maluku Tengah, Indonesia

DOI:

https://doi.org/10.55175/cdk.v50i8.1001

Keywords:

Diabetes melitus tipe 2, herpes zoster, lansia

Abstract

Herpes zoster adalah penyakit neurokutan yang disebabkan oleh virus varicella zoster laten. Lansia dengan diabetes melitus lebih rentan terkena infeksi ini. Kasus: Pria, usia 65 tahun, dengan keluhan lenting disertai nyeri seperti ditusuk di punggung dan dada kiri sekitar 5 hari lalu. Pasien mengidap diabetes melitus tipe 2 (DM tipe 2), rutin mengonsumsi obat hipoglikemik oral (OHO). Diagnosis berdasarkan anamnesis dan temuan klinis yang khas; terapi dengan antivirus, analgetik, dan tetap mengonsumsi OHO.

 

Herpes zoster is a neurocutaneous disease caused by latent varicella zoster virus. Elderlies with diabetic melitus are more susceptible to this infection. Case: A 65-year old male patient with grouped vesicle and stabbing pain in left side of his back and chest since 5 days. The patient had type 2 diabetes mellitus (type 2 DM) treated with oral hypoglycemic agent. Diagnosis was based on anamnesis and typical clinical findings, and treated with antiviral, analgetic, and continued OAD.

Downloads

Download data is not yet available.

References

Pusponegoro EHD. Herpes Zoster. Dalam: Menaldi SLSW, Bramono K, Indriatmi W, editor. Dalam: Ilmu Kesehatan Kulit dan Kelamin. Edisi ke-7. Jakarta: Badan Penerbit FKUI; 2015. p. 121.

Wardani AN. Infeksi Virus Pada Kulit. Dalam: Menaldi SLSW, Rahmayunita G, editor. Dalam: Crash Course Dermatologi dan Venereologi. Edisi ke-1. Singapura: Elsevier; 2019. p. 149.

Levin MJ, Schmader KE, Oxman MN. Varicella and Herpes Zoster. Dalam: Kang S, Amagai M, Bruckner AL, Alexander H, Margolis DJ, McMichael AJ, et al., eds. Fitzpatrick’s Dermatology. Edisi ke-9. New York: Mc Graw-Hill; 2019. pp. 3036-9, 3041-51, 3053-8.

James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Andrews’ Diseases of the Skin Clinical Dermatology. Edisi 13. Edinburgh: Elsevier; 2020. p. 374.

Papagianni M, Metallidis S, Tziomalos K. Herpes Zoster and diabetes mellitus: a review. Diabetes Ther [internet]. 2018 Mar; 545–50. https://doi.org/10.1007/s13300-018-0394-4

Suaya JA, Chen SY, Li Q, Burstin SJ, Levin MJ. Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States. Open Forum Infect Dis [internet]. 2014 Aug; 1-11. https://doi.org/10.1093/ofid/ofu049

Ke CC, Lai HC, Lin CH, et al. Increased risk of herpes zoster in diabetic patients comorbid with coronary artery disease and microvascular disorders: a population-based study in Taiwan. PLoS ONE [internet]. 2016 Jan; 1-10. Available from: https://doi.org/10.1371/journal.pone.0146750

Chen HH, Lin IC, Chen HJ, Yeh SY, Kao CH. Association of herpes zoster and type 1 diabetes mellitus. PLoS ONE [internet]. 2016 May; 1-8. Available from: https://doi.org/10.1371/journal.pone.0155175

Chen HH, Lin CL, Yeh SY, Kao CH. Short-term dipeptidyl peptidase-4 inhibitor use increases the risk of herpes zoster infection in Asian patients with diabetes. QJM [internet]. 2016 Feb; 91–5. Available from: 10.1093/qjmed/hcv096

Pusponegoro EHD, Nilasari H, Lumintang H, Niode NJ, Daili SF, Djauzi S, editor. Buku Panduan Herpes Zoster di Indonesia. Jakarta: Badan Penerbit FKUI; 2014. p.13-6, 25-9, 38-40.

Han Y, Zhang J, Chen N, He L, Zhou M, Zhu C. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database SystRev [internet]. 2013 Mar; 1-15. Available from: DOI: 10.1002/14651858.CD005582.pub4

Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc [internet]. 2017 Dec; 1806-21. Available from: DOI: 10.1016/j.mayocp.2017.10.009

Downloads

Published

02-08-2023

How to Cite

Kaihatu, O. C. (2023). Herpes Zoster pada Lansia Diabetes Melitus. Cermin Dunia Kedokteran, 50(8), 429–432. https://doi.org/10.55175/cdk.v50i8.1001